PDB_ID PUBMED_CID STRUCTURE TITLE DEPOSITION DATE RELEASE DATE AUTHORS CITATION TITLE JOURNAL YEAR VOLUME FIRST PAGE LAST PAGE 6XC2 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 6XC3 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 6XC4 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 6XC7 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 7JMO 33027617 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 2020-08-02 2020-08-26 Wu, N.C.,Yuan, M.,Liu, H.,Lee, C.D.,Zhu, X.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep 2020 33 108274 108274 7JMP 33027617 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 2020-08-02 2020-08-26 Wu, N.C.,Yuan, M.,Liu, H.,Lee, C.D.,Zhu, X.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep 2020 33 108274 108274 6XKP 33058755 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270 2020-06-26 2020-10-14 Kreye, J.,Reincke, S.M.,Kornau, H.C.,Sanchez-Sendin, E.,Corman, V.M.,Liu, H.,Yuan, M.,Wu, N.C.,Zhu, X.,Lee, C.D.,Trimpert, J.,Holtje, M.,Dietert, K.,Stoffler, L.,von Wardenburg, N.,van Hoof, S.,Homeyer, M.A.,Hoffmann, J.,Abdelgawad, A.,Gruber, A.D.,Bertzbach, L.D.,Vladimirova, D.,Li, L.Y.,Barthel, P.C.,Skriner, K.,Hocke, A.C.,Hippenstiel, S.,Witzenrath, M.,Suttorp, N.,Kurth, F.,Franke, C.,Endres, M.,Schmitz, D.,Jeworowski, L.M.,Richter, A.,Schmidt, M.L.,Schwarz, T.,Muller, M.A.,Drosten, C.,Wendisch, D.,Sander, L.E.,Osterrieder, N.,Wilson, I.A.,Pruss, H. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell 2020 183 1058 0 6XKQ 33058755 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250 2020-06-26 2020-10-14 Kreye, J.,Reincke, S.M.,Kornau, H.C.,Sanchez-Sendin, E.,Corman, V.M.,Liu, H.,Yuan, M.,Wu, N.C.,Zhu, X.,Lee, C.D.,Trimpert, J.,Holtje, M.,Dietert, K.,Stoffler, L.,von Wardenburg, N.,van Hoof, S.,Homeyer, M.A.,Hoffmann, J.,Abdelgawad, A.,Gruber, A.D.,Bertzbach, L.D.,Vladimirova, D.,Li, L.Y.,Barthel, P.C.,Skriner, K.,Hocke, A.C.,Hippenstiel, S.,Witzenrath, M.,Suttorp, N.,Kurth, F.,Franke, C.,Endres, M.,Schmitz, D.,Jeworowski, L.M.,Richter, A.,Schmidt, M.L.,Schwarz, T.,Muller, M.A.,Drosten, C.,Wendisch, D.,Sander, L.E.,Osterrieder, N.,Wilson, I.A.,Pruss, H. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell 2020 183 1058 0 7JMW 33242394 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab 2020-08-03 2020-10-14 Liu, H.,Wu, N.C.,Yuan, M.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,van Schooten, J.,Zhu, X.,Lee, C.D.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity 2020 53 1272 0 7JMX 33242394 Crystal structure of a SARS-CoV-2 cross-neutralizing antibody COVA1-16 Fab 2020-08-03 2020-10-14 Liu, H.,Wu, N.C.,Yuan, M.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,van Schooten, J.,Zhu, X.,Lee, C.D.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity 2020 53 1272 0 7K8M 33045718 Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8N 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C102 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8O 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C002 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8P 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C110 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8Q 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C121 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8R 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C135 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 5RSM 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000001099 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSN 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000064576 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSO 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000000226 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSP 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002560357 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSQ 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158490 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSR 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158650 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSS 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006691828 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RST 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332673 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSU 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000002055 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSV 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000340465 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSW 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000337835 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSX 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388262 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSY 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004787230 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSZ 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004218283 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT0 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002582714 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT1 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000039810 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT2 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000008652361 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT3 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000039281982 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT4 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000051581 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT5 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000058111 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT6 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000156509 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT7 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000015442276 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT8 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000161908 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT9 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388280 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTA 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332540 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTB 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006534965 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTC 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006490906 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTD 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000157108 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 7KN5 33436526 Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U 2020-11-04 2021-01-20 Koenig, P.A.,Das, H.,Liu, H.,Kummerer, B.M.,Gohr, F.N.,Jenster, L.M.,Schiffelers, L.D.J.,Tesfamariam, Y.M.,Uchima, M.,Wuerth, J.D.,Gatterdam, K.,Ruetalo, N.,Christensen, M.H.,Fandrey, C.I.,Normann, S.,Todtmann, J.M.P.,Pritzl, S.,Hanke, L.,Boos, J.,Yuan, M.,Zhu, X.,Schmid-Burgk, J.L.,Kato, H.,Schindler, M.,Wilson, I.A.,Geyer, M.,Ludwig, K.U.,Hallberg, B.M.,Wu, N.C.,Schmidt, F.I. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 2021 371 0 0 7KN6 33436526 Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3 2020-11-04 2021-01-20 Koenig, P.A.,Das, H.,Liu, H.,Kummerer, B.M.,Gohr, F.N.,Jenster, L.M.,Schiffelers, L.D.J.,Tesfamariam, Y.M.,Uchima, M.,Wuerth, J.D.,Gatterdam, K.,Ruetalo, N.,Christensen, M.H.,Fandrey, C.I.,Normann, S.,Todtmann, J.M.P.,Pritzl, S.,Hanke, L.,Boos, J.,Yuan, M.,Zhu, X.,Schmid-Burgk, J.L.,Kato, H.,Schindler, M.,Wilson, I.A.,Geyer, M.,Ludwig, K.U.,Hallberg, B.M.,Wu, N.C.,Schmidt, F.I. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 2021 371 0 0 7L61 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L62 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L63 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L64 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L65 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L66 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L67 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Fuc-(alpha1-3)-GlcNAc 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L68 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7LKA 34155209 Crystal structure of SARS-CoV-2 RBD-targeting antibody COV107-23 2021-02-02 2021-02-10 Tan, T.J.C.,Yuan, M.,Kuzelka, K.,Padron, G.C.,Beal, J.R.,Chen, X.,Wang, Y.,Rivera-Cardona, J.,Zhu, X.,Stadtmueller, B.M.,Brooke, C.B.,Wilson, I.A.,Wu, N.C. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain. Nat Commun 2021 12 3815 3815 7LK9 34155209 Crystal structure of SARS-CoV-2 RBD-targeting antibody COV107-23 HC + COVD21-C8 LC 2021-02-01 2021-02-17 Tan, T.J.C.,Yuan, M.,Kuzelka, K.,Padron, G.C.,Beal, J.R.,Chen, X.,Wang, Y.,Rivera-Cardona, J.,Zhu, X.,Stadtmueller, B.M.,Brooke, C.B.,Wilson, I.A.,Wu, N.C. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain. Nat Commun 2021 12 3815 3815 7KS8 34110801 Crystal structure of human CYP3A4 with the caged inhibitor 2020-11-21 2021-06-02 Toupin, N.,Steinke, S.J.,Nadella, S.,Li, A.,Rohrabaugh Jr., T.N.,Samuels, E.R.,Turro, C.,Sevrioukova, I.F.,Kodanko, J.J. Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4. J.Am.Chem.Soc. 2021 143 9191 9205 7MBI 34242027 Structure of SARS-CoV2 3CL protease covalently bound to peptidomimetic inhibitor 2021-03-31 2021-07-21 Bai, B.,Belovodskiy, A.,Hena, M.,Kandadai, A.S.,Joyce, M.A.,Saffran, H.A.,Shields, J.A.,Khan, M.B.,Arutyunova, E.,Lu, J.,Bajwa, S.K.,Hockman, D.,Fischer, C.,Lamer, T.,Vuong, W.,van Belkum, M.J.,Gu, Z.,Lin, F.,Du, Y.,Xu, J.,Rahim, M.,Young, H.S.,Vederas, J.C.,Tyrrell, D.L.,Lemieux, M.J.,Nieman, J.A. Peptidomimetic alpha-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability. J.Med.Chem. 2022 65 2905 2925 7R7H 34778773 Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors 2021-06-24 2021-09-01 Bai, B.,Arutyunova, E.,Khan, M.B.,Lu, J.,Joyce, M.A.,Saffran, H.A.,Shields, J.A.,Kandadai, A.S.,Belovodskiy, A.,Hena, M.,Vuong, W.,Lamer, T.,Young, H.S.,Vederas, J.C.,Tyrrell, D.L.,Lemieux, M.J.,Nieman, J.A. Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors. Rsc Med Chem 2021 12 1722 1730 7LQ7 34519517 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 2021-02-13 2021-09-15 Cho, H.,Gonzales-Wartz, K.K.,Huang, D.,Yuan, M.,Peterson, M.,Liang, J.,Beutler, N.,Torres, J.L.,Cong, Y.,Postnikova, E.,Bangaru, S.,Talana, C.A.,Shi, W.,Yang, E.S.,Zhang, Y.,Leung, K.,Wang, L.,Peng, L.,Skinner, J.,Li, S.,Wu, N.C.,Liu, H.,Dacon, C.,Moyer, T.,Cohen, M.,Zhao, M.,Lee, F.E.,Weinberg, R.S.,Douagi, I.,Gross, R.,Schmaljohn, C.,Pegu, A.,Mascola, J.R.,Holbrook, M.,Nemazee, D.,Rogers, T.F.,Ward, A.B.,Wilson, I.A.,Crompton, P.D.,Tan, J. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern. Sci Transl Med 2021 13 0 0 7SI0 34862384 IgE-Fc in complex with 813 2021-10-12 2021-12-15 Pennington, L.F.,Gasser, P.,Kleinboelting, S.,Zhang, C.,Skiniotis, G.,Eggel, A.,Jardetzky, T.S. Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex. Nat Commun 2021 12 7069 7069 7RT4 34889605 KRAS G12D in complex with Compound 5B (7-(8-chloronaphthalen-1-yl)-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-4-(piperazin-1-yl)pyrido[4,3-d]pyrimidine) 2021-08-12 2021-12-22 Wang, X.,Allen, S.,Blake, J.F.,Bowcut, V.,Briere, D.M.,Calinisan, A.,Dahlke, J.R.,Fell, J.B.,Fischer, J.P.,Gunn, R.J.,Hallin, J.,Laguer, J.,Lawson, J.D.,Medwid, J.,Newhouse, B.,Nguyen, P.,O'Leary, J.M.,Olson, P.,Pajk, S.,Rahbaek, L.,Rodriguez, M.,Smith, C.R.,Tang, T.P.,Thomas, N.C.,Vanderpool, D.,Vigers, G.P.,Christensen, J.G.,Marx, M.A. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor. J.Med.Chem. 2022 65 3123 3133 7SJS 35133175 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8 2021-10-18 2022-01-12 Zhou, P.,Yuan, M.,Song, G.,Beutler, N.,Shaabani, N.,Huang, D.,He, W.T.,Zhu, X.,Callaghan, S.,Yong, P.,Anzanello, F.,Peng, L.,Ricketts, J.,Parren, M.,Garcia, E.,Rawlings, S.A.,Smith, D.M.,Nemazee, D.,Teijaro, J.R.,Rogers, T.F.,Wilson, I.A.,Burton, D.R.,Andrabi, R. A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Sci Transl Med 2022 14 0 0 7LEQ 35260573 Structure of importin a2 bound to p50 NLS 2021-01-14 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7LET 35260573 Structure of importin a2 bound to the p50- and p65-NLSs 2021-01-15 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7LF4 35260573 Structure of importin a3 bound to the p50- and p65-NLSs 2021-01-15 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7LFC 35260573 Structure of importin a3 bound to p50 NLS 2021-01-16 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7RYU 35136084 Anti-HIV neutralizing antibody Ab1303 Fab isolated from sequentially immunized mcaques 2021-08-26 2022-01-19 Yang, Z.,Dam, K.A.,Bridges, M.D.,Hoffmann, M.A.G.,DeLaitsch, A.T.,Gristick, H.B.,Escolano, A.,Gautam, R.,Martin, M.A.,Nussenzweig, M.C.,Hubbell, W.L.,Bjorkman, P.J. Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer. Nat Commun 2022 13 732 732 7RYV 35136084 Anti-HIV neutralizing antibody Ab1573 Fab isolated from sequentially immunized macaques 2021-08-26 2022-01-19 Yang, Z.,Dam, K.A.,Bridges, M.D.,Hoffmann, M.A.G.,DeLaitsch, A.T.,Gristick, H.B.,Escolano, A.,Gautam, R.,Martin, M.A.,Nussenzweig, M.C.,Hubbell, W.L.,Bjorkman, P.J. Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer. Nat Commun 2022 13 732 732 7TP3 35947674 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K288.2 2022-01-24 2022-02-23 He, W.T.,Yuan, M.,Callaghan, S.,Musharrafieh, R.,Song, G.,Silva, M.,Beutler, N.,Lee, W.H.,Yong, P.,Torres, J.L.,Melo, M.,Zhou, P.,Zhao, F.,Zhu, X.,Peng, L.,Huang, D.,Anzanello, F.,Ricketts, J.,Parren, M.,Garcia, E.,Ferguson, M.,Rinaldi, W.,Rawlings, S.A.,Nemazee, D.,Smith, D.M.,Briney, B.,Safonova, Y.,Rogers, T.F.,Dan, J.M.,Zhang, Z.,Weiskopf, D.,Sette, A.,Crotty, S.,Irvine, D.J.,Ward, A.B.,Wilson, I.A.,Burton, D.R.,Andrabi, R. Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques. Sci Transl Med 2022 14 0 0 7TWF 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 73 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7TWG 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 153 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7TWH 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 290 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7TWI 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 539 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7S5Q 35076281 Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 2021-09-11 2022-03-09 Reincke, S.M.,Yuan, M.,Kornau, H.C.,Corman, V.M.,van Hoof, S.,Sanchez-Sendin, E.,Ramberger, M.,Yu, W.,Hua, Y.,Tien, H.,Schmidt, M.L.,Schwarz, T.,Jeworowski, L.M.,Brandl, S.E.,Rasmussen, H.F.,Homeyer, M.A.,Stoffler, L.,Barner, M.,Kunkel, D.,Huo, S.,Horler, J.,von Wardenburg, N.,Kroidl, I.,Eser, T.M.,Wieser, A.,Geldmacher, C.,Hoelscher, M.,Ganzer, H.,Weiss, G.,Schmitz, D.,Drosten, C.,Pruss, H.,Wilson, I.A.,Kreye, J. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science 2022 375 782 787 7S5R 35076281 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 2021-09-11 2022-03-09 Reincke, S.M.,Yuan, M.,Kornau, H.C.,Corman, V.M.,van Hoof, S.,Sanchez-Sendin, E.,Ramberger, M.,Yu, W.,Hua, Y.,Tien, H.,Schmidt, M.L.,Schwarz, T.,Jeworowski, L.M.,Brandl, S.E.,Rasmussen, H.F.,Homeyer, M.A.,Stoffler, L.,Barner, M.,Kunkel, D.,Huo, S.,Horler, J.,von Wardenburg, N.,Kroidl, I.,Eser, T.M.,Wieser, A.,Geldmacher, C.,Hoelscher, M.,Ganzer, H.,Weiss, G.,Schmitz, D.,Drosten, C.,Pruss, H.,Wilson, I.A.,Kreye, J. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science 2022 375 782 787 7S2R 35325595 nanobody bound to IL-2Rg 2021-09-03 2022-03-30 Yen, M.,Ren, J.,Liu, Q.,Glassman, C.R.,Sheahan, T.P.,Picton, L.K.,Moreira, F.R.,Rustagi, A.,Jude, K.M.,Zhao, X.,Blish, C.A.,Baric, R.S.,Su, L.L.,Garcia, K.C. Facile discovery of surrogate cytokine agonists. Cell 2022 185 1414 0 7U0N 35343765 Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2 2022-02-18 2022-03-30 Geng, Q.,Shi, K.,Ye, G.,Zhang, W.,Aihara, H.,Li, F. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1. J.Virol. 2022 96 0 0 7RDH 35332283 Crystal structure of the de novo designed binding protein H3mb in complex with the 1968 influenza A virus hemagglutinin 2021-07-09 2022-05-04 Cao, L.,Coventry, B.,Goreshnik, I.,Huang, B.,Sheffler, W.,Park, J.S.,Jude, K.M.,Markovic, I.,Kadam, R.U.,Verschueren, K.H.G.,Verstraete, K.,Walsh, S.T.R.,Bennett, N.,Phal, A.,Yang, A.,Kozodoy, L.,DeWitt, M.,Picton, L.,Miller, L.,Strauch, E.M.,DeBouver, N.D.,Pires, A.,Bera, A.K.,Halabiya, S.,Hammerson, B.,Yang, W.,Bernard, S.,Stewart, L.,Wilson, I.A.,Ruohola-Baker, H.,Schlessinger, J.,Lee, S.,Savvides, S.N.,Garcia, K.C.,Baker, D. Design of protein-binding proteins from the target structure alone. Nature 2022 605 551 560 7U2E 35767670 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688 2022-02-23 2022-05-04 Yuan, M.,Zhu, X.,He, W.T.,Zhou, P.,Kaku, C.I.,Capozzola, T.,Zhu, C.Y.,Yu, X.,Liu, H.,Yu, W.,Hua, Y.,Tien, H.,Peng, L.,Song, G.,Cottrell, C.A.,Schief, W.R.,Nemazee, D.,Walker, L.M.,Andrabi, R.,Burton, D.R.,Wilson, I.A. A broad and potent neutralization epitope in SARS-related coronaviruses. Proc.Natl.Acad.Sci.USA 2022 119 0 0 7SBU 35549549 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab 2021-09-25 2022-05-11 Torres, J.L.,Ozorowski, G.,Andreano, E.,Liu, H.,Copps, J.,Piccini, G.,Donnici, L.,Conti, M.,Planchais, C.,Planas, D.,Manganaro, N.,Pantano, E.,Paciello, I.,Pileri, P.,Bruel, T.,Montomoli, E.,Mouquet, H.,Schwartz, O.,Sala, C.,De Francesco, R.,Wilson, I.A.,Rappuoli, R.,Ward, A.B. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody. Proc.Natl.Acad.Sci.USA 2022 119 0 0 7SJJ 35467853 Crystal structure of photoactive yellow protein (PYP); F96oCNF construct 2021-10-17 2022-05-11 Weaver, J.B.,Kozuch, J.,Kirsh, J.M.,Boxer, S.G. Nitrile Infrared Intensities Characterize Electric Fields and Hydrogen Bonding in Protic, Aprotic, and Protein Environments. J.Am.Chem.Soc. 2022 144 7562 7567 7SPV 35467853 Crystal structure of photoactive yellow protein (PYP); F92oCNF construct 2021-11-03 2022-05-11 Weaver, J.B.,Kozuch, J.,Kirsh, J.M.,Boxer, S.G. Nitrile Infrared Intensities Characterize Electric Fields and Hydrogen Bonding in Protic, Aprotic, and Protein Environments. J.Am.Chem.Soc. 2022 144 7562 7567 7SPW 35467853 Crystal structure of photoactive yellow protein (PYP); F62oCNF construct 2021-11-03 2022-05-11 Weaver, J.B.,Kozuch, J.,Kirsh, J.M.,Boxer, S.G. Nitrile Infrared Intensities Characterize Electric Fields and Hydrogen Bonding in Protic, Aprotic, and Protein Environments. J.Am.Chem.Soc. 2022 144 7562 7567 7URY 36942575 Tetradecameric hub domain of CaMKII beta 2022-04-22 2022-05-11 Saha, S.,Ozden, C.,Samkutty, A.,Russi, S.,Cohen, A.,Stratton, M.M.,Perry, S.L. Polymer-based microfluidic device for on-chip counter-diffusive crystallization and in situ X-ray crystallography at room temperature. Lab Chip 2023 23 2075 2090 7SV2 35398097 Human Cytochrome P450 (CYP) 3A5 ternary complex with azamulin 2021-11-18 2022-05-18 Hsu, M.H.,Johnson, E.F. Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5. J.Biol.Chem. 2022 298 101909 101909 7S3B 35524551 Crystal structure of intact U2AF65 RRM-region bound to AdML-G5 oligonucleotide 2021-09-05 2022-05-25 Glasser, E.,Maji, D.,Biancon, G.,Puthenpeedikakkal, A.M.K.,Cavender, C.E.,Tebaldi, T.,Jenkins, J.L.,Mathews, D.H.,Halene, S.,Kielkopf, C.L. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal. Nucleic Acids Res. 2022 50 5299 5312 7S3C 35524551 Crystal structure of intact U2AF65 RRM-region bound to AdML-A5 oligonucleotide 2021-09-05 2022-05-25 Glasser, E.,Maji, D.,Biancon, G.,Puthenpeedikakkal, A.M.K.,Cavender, C.E.,Tebaldi, T.,Jenkins, J.L.,Mathews, D.H.,Halene, S.,Kielkopf, C.L. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal. Nucleic Acids Res. 2022 50 5299 5312 7RAD Crystal Structure Analysis of ALDH1B1 2021-07-01 2022-06-08 Fernandez, D. Inhibitors targeted to aldehyde dehydrogenase Nat.Chem.Biol. 2022 0 0 0 5SS0 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCn9000000uj1v 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS1 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCou000000a2Hm 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS2 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCnt000006kx7L 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS3 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCnu000001eLaQ 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS4 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCns000000RJoU 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS5 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCpE000000mAwk - (S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS6 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINClf00000cdzal 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS7 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCnz000004Qo8S 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS8 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCny000002NPIr 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS9 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCow000000AiWv - (R) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSA 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINClv000001jcNa - (r,r) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSB 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCmk000007RhkC 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSC 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCk500000doQ8X 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSD 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCm4000007vvRA - (R,S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSE 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCoD000001aHBe 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSF 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCmr000000sTGN 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSG 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCpv000006Li5M - (R,R) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSH 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCpx000006Mh4L - (S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSI 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCn500000bifGU 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSJ 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCno00000broQT 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSK 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCkk00000cjQyM - (R,S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSL 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCoj00000doMWF 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSM 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166256 - (R,R) and (S,S) isomers 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSN 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5010894382 - (R,S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSO 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5198562519 - (R) and (S) isomers 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSP 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166285 - (R,R) and (S,S) isomers 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSQ 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166291 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSR 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166300 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SP4 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z4718398572 2022-06-09 2022-07-13 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 7UFD 35806297 Human CYP3A4 bound to an inhibitor 2022-03-22 2022-07-27 Samuels, E.R.,Sevrioukova, I.F. Interaction of CYP3A4 with Rationally Designed Ritonavir Analogues: Impact of Steric Constraints Imposed on the Heme-Ligating Group and the End-Pyridine Attachment. Int J Mol Sci 2022 23 0 0 8D36 35857439 Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62 2022-05-31 2022-07-27 Dacon, C.,Tucker, C.,Peng, L.,Lee, C.D.,Lin, T.H.,Yuan, M.,Cong, Y.,Wang, L.,Purser, L.,Williams, J.K.,Pyo, C.W.,Kosik, I.,Hu, Z.,Zhao, M.,Mohan, D.,Cooper, A.J.R.,Peterson, M.,Skinner, J.,Dixit, S.,Kollins, E.,Huzella, L.,Perry, D.,Byrum, R.,Lembirik, S.,Drawbaugh, D.,Eaton, B.,Zhang, Y.,Yang, E.S.,Chen, M.,Leung, K.,Weinberg, R.S.,Pegu, A.,Geraghty, D.E.,Davidson, E.,Douagi, I.,Moir, S.,Yewdell, J.W.,Schmaljohn, C.,Crompton, P.D.,Holbrook, M.R.,Nemazee, D.,Mascola, J.R.,Wilson, I.A.,Tan, J. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science 2022 377 728 735 8D6Z 35857439 Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV91-27 2022-06-06 2022-07-27 Dacon, C.,Tucker, C.,Peng, L.,Lee, C.D.,Lin, T.H.,Yuan, M.,Cong, Y.,Wang, L.,Purser, L.,Williams, J.K.,Pyo, C.W.,Kosik, I.,Hu, Z.,Zhao, M.,Mohan, D.,Cooper, A.J.R.,Peterson, M.,Skinner, J.,Dixit, S.,Kollins, E.,Huzella, L.,Perry, D.,Byrum, R.,Lembirik, S.,Drawbaugh, D.,Eaton, B.,Zhang, Y.,Yang, E.S.,Chen, M.,Leung, K.,Weinberg, R.S.,Pegu, A.,Geraghty, D.E.,Davidson, E.,Douagi, I.,Moir, S.,Yewdell, J.W.,Schmaljohn, C.,Crompton, P.D.,Holbrook, M.R.,Nemazee, D.,Mascola, J.R.,Wilson, I.A.,Tan, J. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science 2022 377 728 735 7T7B 35906394 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab 2021-12-14 2022-08-03 Liu, H.,Kaku, C.I.,Song, G.,Yuan, M.,Andrabi, R.,Burton, D.R.,Walker, L.M.,Wilson, I.A. Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. Commun Biol 2022 5 766 766 7SEI 35065072 Glucose-6-phosphate 1-dehydrogenase (K403Q) 2021-09-30 2022-08-17 Garcia, A.A.,Mathews, I.I.,Horikoshi, N.,Matsui, T.,Kaur, M.,Wakatsuki, S.,Mochly-Rosen, D. Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants. J.Biol.Chem. 2022 298 101610 101610 8DGG Structure of glycosylated LAG-3 homodimer 2022-06-23 2022-08-17 Silberstein, J.L.,Mathews, I.I.,Cochran, J.R. Structural basis for LAG-3 dimeric association and inhibition of T cell function To Be Published 0 0 0 0 7RSS 36124684 Kod-RI incorporating DNA, n+2 2021-08-11 2022-08-24 Hajjar, M.,Chim, N.,Liu, C.,Herdewijn, P.,Chaput, J.C. Crystallographic analysis of engineered polymerases synthesizing phosphonomethylthreosyl nucleic acid. Nucleic Acids Res. 2022 50 9663 9674 7U0K 35922441 IOMA class antibody Fab ACS124 2022-02-18 2022-08-24 van Schooten, J.,Farokhi, E.,Schorcht, A.,van den Kerkhof, T.L.G.M.,Gao, H.,van der Woude, P.,Burger, J.A.,Meesters, T.G.R.,Bijl, T.,Ghalaiyini, R.,Turner, H.L.,Dorning, J.,van Schaik, B.D.C.,van Kampen, A.H.C.,Labranche, C.C.,Stanfield, R.L.,Sok, D.,Montefiori, D.C.,Burton, D.R.,Seaman, M.S.,Ozorowski, G.,Wilson, I.A.,Sanders, R.W.,Ward, A.B.,van Gils, M.J. Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein. Nat Commun 2022 13 4515 4515 8DZU Crystal structure of photoactive yellow protein (PYP); F96oCNF M100H construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8DZX Crystal structure of photoactive yellow protein (PYP); F96oCNF M100K construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8DZY Crystal structure of photoactive yellow protein (PYP); F96oCNF I49T construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E02 Crystal structure of photoactive yellow protein (PYP); F96oCNF T103V construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E03 Crystal structure of photoactive yellow protein (PYP); F96oCNF M100D construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E09 Crystal structure of photoactive yellow protein (PYP); F96oCNF M100E construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E1K Crystal structure of photoactive yellow protein (PYP); F96oCNF M100Q construct 2022-08-10 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E1L Crystal structure of photoactive yellow protein (PYP); F96oCNF M100N construct 2022-08-10 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8DE2 36324090 TEM-1 beta-lactamase A237Y mutant covalently bound to avibactam, a room temperature structure 2022-06-19 2022-09-07 Ji, Z.,Kozuch, J.,Mathews, I.I.,Diercks, C.S.,Shamsudin, Y.,Schulz, M.A.,Boxer, S.G. Protein Electric Fields Enable Faster and Longer-Lasting Covalent Inhibition of beta-Lactamases. J.Am.Chem.Soc. 2022 144 20947 20954 8DKR 36007626 Pseudomonas-phage E217 TerL nuclease domain 2022-07-06 2022-09-07 Lokareddy, R.K.,Hou, C.D.,Doll, S.G.,Li, F.,Gillilan, R.E.,Forti, F.,Horner, D.S.,Briani, F.,Cingolani, G. Terminase Subunits from the Pseudomonas-Phage E217. J.Mol.Biol. 2022 434 167799 167799 7SF1 38478629 SARS-CoV-2 Main Protease (Mpro) in Complex with ML1001 2021-10-02 2022-10-05 Westberg, M.,Su, Y.,Zou, X.,Huang, P.,Rustagi, A.,Garhyan, J.,Patel, P.B.,Fernandez, D.,Wu, Y.,Hao, C.,Lo, C.W.,Karim, M.,Ning, L.,Beck, A.,Saenkham-Huntsinger, P.,Tat, V.,Drelich, A.,Peng, B.H.,Einav, S.,Tseng, C.K.,Blish, C.,Lin, M.Z. An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Sci Transl Med 2024 16 0 0 7UFK 36256797 Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2 2022-03-22 2022-10-19 Zhang, W.,Shi, K.,Geng, Q.,Ye, G.,Aihara, H.,Li, F. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant. Proc.Natl.Acad.Sci.USA 2022 119 0 0 7UFL 36256797 Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2 2022-03-22 2022-10-19 Zhang, W.,Shi, K.,Geng, Q.,Ye, G.,Aihara, H.,Li, F. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant. Proc.Natl.Acad.Sci.USA 2022 119 0 0 8EKF 37507365 X-ray crystal structure of 311R Fab in complex with the PfCSP peptide NPNA-3 2022-09-20 2022-10-19 Martin, G.M.,Torres, J.L.,Pholcharee, T.,Oyen, D.,Flores-Garcia, Y.,Gibson, G.,Moskovitz, R.,Beutler, N.,Jung, D.D.,Copps, J.,Lee, W.H.,Gonzalez-Paez, G.,Emerling, D.,MacGill, R.S.,Locke, E.,King, C.R.,Zavala, F.,Wilson, I.A.,Ward, A.B. Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection. Nat Commun 2023 14 4546 4546 7SHV Crystal structure of BRAF kinase domain bound to GDC0879 2021-10-11 2022-10-26 Chen, X.,Wendorff, T.,Jao, C.,Kung, J.E.,Liau, N.P.D.,Wu, P.,Yu, C.,Oh, A.,Boenig, G.,Wallweber, H.,Everett, C.,Miu, A.,Brillantes, B.,Mortara, K.,Murray, J.,Koth, C.M.,Sudhamsu, J. Clearing the Path to Rapid High-Quality Protein Purification To Be Published 0 0 0 0 7U5G 36395347 ACS122 Fab 2022-03-02 2022-11-02 van Schooten, J.,Schorcht, A.,Farokhi, E.,Umotoy, J.C.,Gao, H.,van den Kerkhof, T.L.G.M.,Dorning, J.,Rijkhold Meesters, T.G.,van der Woude, P.,Burger, J.A.,Bijl, T.,Ghalaiyini, R.,Torrents de la Pena, A.,Turner, H.L.,Labranche, C.C.,Stanfield, R.L.,Sok, D.,Schuitemaker, H.,Montefiori, D.C.,Burton, D.R.,Ozorowski, G.,Seaman, M.S.,Wilson, I.A.,Sanders, R.W.,Ward, A.B.,van Gils, M.J. Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer. Plos Pathog. 2022 18 0 0 7FR0 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890182452 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR1 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z1423250928 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR2 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5551425673 - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR3 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A01A - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR4 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A26A - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR5 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890189003 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR6 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890147894 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR7 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z431872694 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR8 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890408258 - (R) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR9 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z1367095370 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRA PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z1343520564 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRB PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5551426009 - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRC PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A05 - (R) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRD PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A25A - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7TR4 36593402 MA2-MART1-HLAA0201 2022-01-27 2022-11-23 Yang, X.,Nishimiya, D.,Lochte, S.,Jude, K.M.,Borowska, M.,Savvides, C.S.,Dougan, M.,Su, L.,Zhao, X.,Piehler, J.,Garcia, K.C. Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapy. Nat.Biotechnol. 2023 41 932 943 8DTX 36347257 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV89-22 2022-07-26 2022-11-23 Dacon, C.,Peng, L.,Lin, T.H.,Tucker, C.,Lee, C.D.,Cong, Y.,Wang, L.,Purser, L.,Cooper, A.J.R.,Williams, J.K.,Pyo, C.W.,Yuan, M.,Kosik, I.,Hu, Z.,Zhao, M.,Mohan, D.,Peterson, M.,Skinner, J.,Dixit, S.,Kollins, E.,Huzella, L.,Perry, D.,Byrum, R.,Lembirik, S.,Murphy, M.,Zhang, Y.,Yang, E.S.,Chen, M.,Leung, K.,Weinberg, R.S.,Pegu, A.,Geraghty, D.E.,Davidson, E.,Doranz, B.J.,Douagi, I.,Moir, S.,Yewdell, J.W.,Schmaljohn, C.,Crompton, P.D.,Mascola, J.R.,Holbrook, M.R.,Nemazee, D.,Wilson, I.A.,Tan, J. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe 2023 31 97 0 7N2N 36477533 TCR-antigen complex AS4.2-PRPF3-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2O 36477533 AS4.2-YEIH-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2Q 36477533 AS4.3-YEIH-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2R 36477533 AS4.3-PRPF3-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2S 36477533 AS3.1-PRPF3-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 8CX4 36477533 TCR-antigen complex AS8.4-YEIH-HLA*B27 2022-05-19 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7UTG 36589886 2D9 nanobody to BCL11A-exZF23 fragment 2022-04-26 2022-12-21 Shen, F.,Zheng, G.,Setegne, M.,Tenglin, K.,Izadi, M.,Xie, H.,Zhai, L.,Orkin, S.H.,Dassama, L.M.K. A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin. Acs Cent.Sci. 2022 8 1695 1703 8D47 36701425 fp.006 Fab in complex with SARS-CoV-2 Fusion Peptide 2022-06-01 2022-12-21 Bianchini, F.,Crivelli, V.,Abernathy, M.E.,Guerra, C.,Palus, M.,Muri, J.,Marcotte, H.,Piralla, A.,Pedotti, M.,De Gasparo, R.,Simonelli, L.,Matkovic, M.,Toscano, C.,Biggiogero, M.,Calvaruso, V.,Svoboda, P.,Cervantes Rincon, T.,Fava, T.,Podesvova, L.,Shanbhag, A.A.,Celoria, A.,Sgrignani, J.,Stefanik, M.,Honig, V.,Pranclova, V.,Michalcikova, T.,Prochazka, J.,Guerrini, G.,Mehn, D.,Ciabattini, A.,Abolhassani, H.,Jarrossay, D.,Uguccioni, M.,Medaglini, D.,Pan-Hammarstrom, Q.,Calzolai, L.,Fernandez, D.,Baldanti, F.,Franzetti-Pellanda, A.,Garzoni, C.,Sedlacek, R.,Ruzek, D.,Varani, L.,Cavalli, A.,Barnes, C.O.,Robbiani, D.F. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. Sci Immunol 2023 8 0 0 8DGW 36889306 Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent 2022-06-24 2023-01-25 Zhou, P.,Song, G.,Liu, H.,Yuan, M.,He, W.T.,Beutler, N.,Zhu, X.,Tse, L.V.,Martinez, D.R.,Schafer, A.,Anzanello, F.,Yong, P.,Peng, L.,Dueker, K.,Musharrafieh, R.,Callaghan, S.,Capozzola, T.,Limbo, O.,Parren, M.,Garcia, E.,Rawlings, S.A.,Smith, D.M.,Nemazee, D.,Jardine, J.G.,Safonova, Y.,Briney, B.,Rogers, T.F.,Wilson, I.A.,Baric, R.S.,Gralinski, L.E.,Burton, D.R.,Andrabi, R. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity 2023 56 669 0 7UTW 37563323 Cd-substituted Horse Liver Alcohol Dehydrogenase in Complex with NADH and N-Cyclohexylformamide 2022-04-27 2023-02-01 Zheng, C.,Ji, Z.,Mathews, I.I.,Boxer, S.G. Enhanced active-site electric field accelerates enzyme catalysis. Nat.Chem. 2023 15 1715 1721 8DH0 36635281 T7 RNA polymerase elongation complex with unnatural base dDs 2022-06-24 2023-02-01 Oh, J.,Kimoto, M.,Xu, H.,Chong, J.,Hirao, I.,Wang, D. Structural basis of transcription recognition of a hydrophobic unnatural base pair by T7 RNA polymerase. Nat Commun 2023 14 195 195 8DH1 36635281 T7 RNA polymerase elongation complex with unnatural base dDs-PaTP pair 2022-06-24 2023-02-01 Oh, J.,Kimoto, M.,Xu, H.,Chong, J.,Hirao, I.,Wang, D. Structural basis of transcription recognition of a hydrophobic unnatural base pair by T7 RNA polymerase. Nat Commun 2023 14 195 195 8FFE 36893265 Crystal structure of LRP6 E1E2 domains bound to YW210.09 Fab and engineered XWnt8 peptide 2022-12-08 2023-03-08 Tsutsumi, N.,Hwang, S.,Waghray, D.,Hansen, S.,Jude, K.M.,Wang, N.,Miao, Y.,Glassman, C.R.,Caveney, N.A.,Janda, C.Y.,Hannoush, R.N.,Garcia, K.C. Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discrimination. Proc.Natl.Acad.Sci.USA 2023 120 0 0 7TGP 37815921 E176T/Y188G variant of the internal UBA Domain of HHR23A 2022-01-08 2023-04-12 Rothfuss, M.T.,Becht, D.C.,Zeng, B.,McClelland, L.J.,Yates-Hansen, C.,Bowler, B.E. High-Accuracy Prediction of Stabilizing Surface Mutations to the Three-Helix Bundle, UBA(1), with EmCAST. J.Am.Chem.Soc. 2023 145 22979 22992 8EJ9 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-09-16 2023-04-26 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DI3 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-06-28 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKH 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKJ 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKK 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKL 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8EJ7 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-09-16 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 7U2V 37126705 Plasmodium falciparum Cyt c2 DSD 2022-02-24 2023-05-10 Espino-Sanchez, T.J.,Wienkers, H.,Marvin, R.G.,Nalder, S.A.,Garcia-Guerrero, A.E.,VanNatta, P.E.,Jami-Alahmadi, Y.,Mixon Blackwell, A.,Whitby, F.G.,Wohlschlegel, J.A.,Kieber-Emmons, M.T.,Hill, C.P.,Sigala, P.A. Direct tests of cytochrome c and c1 functions in the electron transport chain of malaria parasites Proc Natl Acad Sci U S A 2023 120 0 0 7UW3 35638584 Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain 2022-05-02 2023-05-10 Sarkar, S.,Runge, B.,Russell, R.W.,Movellan, K.T.,Calero, D.,Zeinalilathori, S.,Quinn, C.M.,Lu, M.,Calero, G.,Gronenborn, A.M.,Polenova, T. Atomic-Resolution Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain. J.Am.Chem.Soc. 2022 144 10543 10555 8GB8 37163615 Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 2023-02-24 2023-05-24 Feng, Y.,Yuan, M.,Powers, J.M.,Hu, M.,Munt, J.E.,Arunachalam, P.S.,Leist, S.R.,Bellusci, L.,Kim, J.,Sprouse, K.R.,Adams, L.E.,Sundaramurthy, S.,Zhu, X.,Shirreff, L.M.,Mallory, M.L.,Scobey, T.D.,Moreno, A.,O'Hagan, D.T.,Kleanthous, H.,Villinger, F.J.,Veesler, D.,King, N.P.,Suthar, M.S.,Khurana, S.,Baric, R.S.,Wilson, I.A.,Pulendran, B. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. Sci Transl Med 2023 15 0 0 8GFB 37209283 Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv16b inhibitor 2023-03-08 2023-05-24 Kumar, V.,Boorman, J.,Greenlee, W.J.,Zeng, X.,Lin, J.,van den Akker, F. Exploring the inhibition of the soluble lytic transglycosylase Cj0843c of Campylobacter jejuni via targeting different sites with different scaffolds. Protein Sci. 2023 32 0 0 8GFC 37209283 Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv17b inhibitor 2023-03-08 2023-05-24 Kumar, V.,Boorman, J.,Greenlee, W.J.,Zeng, X.,Lin, J.,van den Akker, F. Exploring the inhibition of the soluble lytic transglycosylase Cj0843c of Campylobacter jejuni via targeting different sites with different scaffolds. Protein Sci. 2023 32 0 0 8GFQ 37209283 Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv32r inhibitor 2023-03-08 2023-05-24 Kumar, V.,Boorman, J.,Greenlee, W.J.,Zeng, X.,Lin, J.,van den Akker, F. Exploring the inhibition of the soluble lytic transglycosylase Cj0843c of Campylobacter jejuni via targeting different sites with different scaffolds. Protein Sci. 2023 32 0 0 8DAI E. coli DHFR complex with NADP+ and 10-methylfolate 2022-06-13 2023-06-21 Greisman, J.B.,Brookner, D.E.,Hekstra, D.R. E. coli DHFR complex with NADP+ and 10-methylfolate To Be Published 0 0 0 0 8ELO 37276407 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-225 2022-09-26 2023-07-05 Misson Mindrebo, L.,Liu, H.,Ozorowski, G.,Tran, Q.,Woehl, J.,Khalek, I.,Smith, J.M.,Barman, S.,Zhao, F.,Keating, C.,Limbo, O.,Verma, M.,Liu, J.,Stanfield, R.L.,Zhu, X.,Turner, H.L.,Sok, D.,Huang, P.S.,Burton, D.R.,Ward, A.B.,Wilson, I.A.,Jardine, J.G. Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8D0Y Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom 2022-05-26 2023-07-19 Xian, Y.,Wilson, A. The domain-swaped dimer of the HIV-1 CD4bs targeting antibody 21N13 To Be Published 0 0 0 0 8DA4 37499032 Coevolved affibody-Z domain pair LL1.c2 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8DA5 37499032 Coevolved affibody-Z domain pair LL1.c4 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8DA6 37499032 Coevolved affibody-Z domain pair LL1.c5 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8DA7 37499032 Coevolved affibody-Z domain pair LL1.c6 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8P8X 37523899 Crystal structure of a pathogenic mutant variant of human mitochodnrial PheRS 2023-06-03 2023-08-16 Chen, W.,Rehsi, P.,Thompson, K.,Yeo, M.,Stals, K.,He, L.,Schimmel, P.,Chrzanowska-Lightowlers, Z.M.A.,Wakeling, E.,Taylor, R.W.,Kuhle, B. Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease. Mol.Genet.Metab. 2023 140 107657 107657 5SSS DHFR:NADP+:FOL complex at 270 K (crystal 1) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 270 K To Be Published 0 0 0 0 5SST DHFR:NADP+:FOL complex at 270 K (crystal 2) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 270 K To Be Published 0 0 0 0 5SSU DHFR:NADP+:FOL complex at 270 K (crystal 3) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 270 K To Be Published 0 0 0 0 5SSV DHFR:NADP+:FOL complex at 270 K (crystal 4) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 270 K To Be Published 0 0 0 0 5SSW DHFR:NADP+:FOL complex at 270 K (multi-crystal) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 270 K To Be Published 0 0 0 0 8GF2 37582161 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 2023-03-07 2023-08-23 Zhao, F.,Yuan, M.,Keating, C.,Shaabani, N.,Limbo, O.,Joyce, C.,Woehl, J.,Barman, S.,Burns, A.,Tran, Q.,Zhu, X.,Ricciardi, M.,Peng, L.,Smith, J.,Huang, D.,Briney, B.,Sok, D.,Nemazee, D.,Teijaro, J.R.,Wilson, I.A.,Burton, D.R.,Jardine, J.G. Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. Sci.Signal. 2023 16 0 0 8EE3 F93Y Horse Liver Alcohol Dehydrogenase in Complex with NADH and N-Cyclohexylformamide 2022-09-06 2023-09-13 Zheng, C.,Boxer, S.G. Structure of F93Y horse liver alcohol dehydrogenase at 1.55 Angstroms resolution To Be Published 0 0 0 0 7FPL DHFR:NADP+:FOL complex at 280 K (crystal 1) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 280 K To Be Published 0 0 0 0 7FPM DHFR:NADP+:FOL complex at 280 K (crystal 2) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 280 K To Be Published 0 0 0 0 7FPN DHFR:NADP+:FOL complex at 280 K (crystal 3) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 280 K To Be Published 0 0 0 0 7FPO DHFR:NADP+:FOL complex at 280 K (crystal 4) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 280 K To Be Published 0 0 0 0 7FPP DHFR:NADP+:FOL complex at 280 K (crystal 5) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 280 K To Be Published 0 0 0 0 7FPQ DHFR:NADP+:FOL complex at 280 K (multi-crystal) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 280 K To Be Published 0 0 0 0 7FPR DHFR:NADP+:FOL complex at 290 K (crystal 1) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 290 K To Be Published 0 0 0 0 7FPS DHFR:NADP+:FOL complex at 290 K (crystal 2) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 290 K To Be Published 0 0 0 0 7FPT DHFR:NADP+:FOL complex at 290 K (crystal 3) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 290 K To Be Published 0 0 0 0 7FPU DHFR:NADP+:FOL complex at 290 K (crystal 4) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 290 K To Be Published 0 0 0 0 7FPV DHFR:NADP+:FOL complex at 290 K (crystal 5) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 290 K To Be Published 0 0 0 0 7FPW DHFR:NADP+:FOL complex at 290 K (multi-crystal) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 290 K To Be Published 0 0 0 0 7FPX DHFR:NADP+:FOL complex at 300 K (crystal 1) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 300 K To Be Published 0 0 0 0 7FPY DHFR:NADP+:FOL complex at 300 K (crystal 2) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 300 K To Be Published 0 0 0 0 7FPZ DHFR:NADP+:FOL complex at 300 K (crystal 3) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 300 K To Be Published 0 0 0 0 7FQ0 DHFR:NADP+:FOL complex at 300 K (crystal 4) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 300 K To Be Published 0 0 0 0 7FQ1 DHFR:NADP+:FOL complex at 300 K (crystal 5) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 300 K To Be Published 0 0 0 0 7FQ2 DHFR:NADP+:FOL complex at 300 K (multi-crystal) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 300 K To Be Published 0 0 0 0 7FQ3 DHFR:NADP+:FOL complex at 310 K (crystal 1) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 310 K To Be Published 0 0 0 0 7FQ4 DHFR:NADP+:FOL complex at 310 K (crystal 2) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 310 K To Be Published 0 0 0 0 7FQ5 DHFR:NADP+:FOL complex at 310 K (crystal 3) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 310 K To Be Published 0 0 0 0 7FQ6 DHFR:NADP+:FOL complex at 310 K (multi-crystal) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. DHFR:NADP+:FOL complex at 310 K To Be Published 0 0 0 0 7FQ7 DHFR:NADP+:FOL complex (crystal 1, pass 1, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQ8 DHFR:NADP+:FOL complex (crystal 1, pass 2, 310 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQ9 DHFR:NADP+:FOL complex (crystal 1, pass 3, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQA DHFR:NADP+:FOL complex (crystal 1, pass 4, 280 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQB DHFR:NADP+:FOL complex (crystal 1, pass 5, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQC DHFR:NADP+:FOL complex (crystal 2, pass 1, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQD DHFR:NADP+:FOL complex (crystal 2, pass 2, 280 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQE DHFR:NADP+:FOL complex (crystal 2, pass 3, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQF DHFR:NADP+:FOL complex (crystal 2, pass 4, 310 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 7FQG DHFR:NADP+:FOL complex (crystal 2, pass 5, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Hekstra, D.R. Single-crystal, multi-temperature experiment of DHFR:NADP+:FOL complex To Be Published 0 0 0 0 8ECV 37722054 Bovine Fab 2F12 2022-09-02 2023-09-20 Huang, R.,Warner Jenkins, G.,Kim, Y.,Stanfield, R.L.,Singh, A.,Martinez-Yamout, M.,Kroon, G.J.,Torres, J.L.,Jackson, A.M.,Kelley, A.,Shaabani, N.,Zeng, B.,Bacica, M.,Chen, W.,Warner, C.,Radoicic, J.,Joh, J.,Dinali Perera, K.,Sang, H.,Kim, T.,Yao, J.,Zhao, F.,Sok, D.,Burton, D.R.,Allen, J.,Harriman, W.,Mwangi, W.,Chung, D.,Teijaro, J.R.,Ward, A.B.,Dyson, H.J.,Wright, P.E.,Wilson, I.A.,Chang, K.O.,McGregor, D.,Smider, V.V. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8ED1 37722054 Bovine Fab 5C1 2022-09-02 2023-09-20 Huang, R.,Warner Jenkins, G.,Kim, Y.,Stanfield, R.L.,Singh, A.,Martinez-Yamout, M.,Kroon, G.J.,Torres, J.L.,Jackson, A.M.,Kelley, A.,Shaabani, N.,Zeng, B.,Bacica, M.,Chen, W.,Warner, C.,Radoicic, J.,Joh, J.,Dinali Perera, K.,Sang, H.,Kim, T.,Yao, J.,Zhao, F.,Sok, D.,Burton, D.R.,Allen, J.,Harriman, W.,Mwangi, W.,Chung, D.,Teijaro, J.R.,Ward, A.B.,Dyson, H.J.,Wright, P.E.,Wilson, I.A.,Chang, K.O.,McGregor, D.,Smider, V.V. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8EDF 37722054 Bovine Fab SKD in complex with Sars COV-2 receptor binding domain 2022-09-04 2023-09-20 Huang, R.,Warner Jenkins, G.,Kim, Y.,Stanfield, R.L.,Singh, A.,Martinez-Yamout, M.,Kroon, G.J.,Torres, J.L.,Jackson, A.M.,Kelley, A.,Shaabani, N.,Zeng, B.,Bacica, M.,Chen, W.,Warner, C.,Radoicic, J.,Joh, J.,Dinali Perera, K.,Sang, H.,Kim, T.,Yao, J.,Zhao, F.,Sok, D.,Burton, D.R.,Allen, J.,Harriman, W.,Mwangi, W.,Chung, D.,Teijaro, J.R.,Ward, A.B.,Dyson, H.J.,Wright, P.E.,Wilson, I.A.,Chang, K.O.,McGregor, D.,Smider, V.V. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8SG5 37770228 Cytochrome P450 (CYP) 3A5 crystallized with clotrimazole 2023-04-11 2023-10-11 Hsu, M.H.,Johnson, E.F. Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4. Drug Metab.Dispos. 2023 51 1642 1650 8SPD 37770228 Cytochrome P450 (CYP) 3A4 crystallized with clotrimazole 2023-05-02 2023-10-11 Hsu, M.H.,Johnson, E.F. Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4. Drug Metab.Dispos. 2023 51 1642 1650 8UCX Dihydrofolate Reductase Complexed with Folate 2023-09-27 2023-10-11 Fried, S.D.E.,Mukherjee, S.,Mao, Y.,Boxer, S.G. Role of Electrostatics in Hydride Transfer by Dihydrofolate Reductase To Be Published 0 0 0 0 8FZW 37747292 Thaumatin crystallized in cyclic olefin copolymer-based microfluidic chips 2023-01-30 2023-10-18 Liu, Z.,Gu, K.K.,Shelby, M.L.,Gilbile, D.,Lyubimov, A.Y.,Russi, S.,Cohen, A.E.,Narayanasamy, S.R.,Botha, S.,Kupitz, C.,Sierra, R.G.,Poitevin, F.,Gilardi, A.,Lisova, S.,Coleman, M.A.,Frank, M.,Kuhl, T.L. A user-friendly plug-and-play cyclic olefin copolymer-based microfluidic chip for room-temperature, fixed-target serial crystallography. Acta Crystallogr D Struct Biol 2023 79 944 952 7UMI 38198557 Importin a1 bound to Cp183-CTD 2022-04-07 2023-10-25 Yang, R.,Ko, Y.H.,Li, F.,Lokareddy, R.K.,Hou, C.D.,Kim, C.,Klein, S.,Antolinez, S.,Marin, J.F.,Perez-Segura, C.,Jarrold, M.F.,Zlotnick, A.,Hadden-Perilla, J.A.,Cingolani, G. Structural basis for nuclear import of hepatitis B virus (HBV) nucleocapsid core. Sci Adv 2024 10 0 0 8SCY 37747292 Lysozyme crystallized in cyclic olefin copolymer-based microfluidic chips 2023-04-05 2023-10-25 Liu, Z.,Gu, K.K.,Shelby, M.L.,Gilbile, D.,Lyubimov, A.Y.,Russi, S.,Cohen, A.E.,Narayanasamy, S.R.,Botha, S.,Kupitz, C.,Sierra, R.G.,Poitevin, F.,Gilardi, A.,Lisova, S.,Coleman, M.A.,Frank, M.,Kuhl, T.L. A user-friendly plug-and-play cyclic olefin copolymer-based microfluidic chip for room-temperature, fixed-target serial crystallography. Acta Crystallogr D Struct Biol 2023 79 944 952 8FTC 38144257 Crystal structure of main protease of SARS-CoV-2 complexed with inhibitor 2023-01-11 2023-12-06 Arutyunova, E.,Belovodskiy, A.,Chen, P.,Khan, M.B.,Joyce, M.,Saffran, H.,Lu, J.,Turner, Z.,Bai, B.,Lamer, T.,Young, H.S.,Vederas, J.C.,Tyrrell, D.L.,Lemieux, M.J.,Nieman, J.A. The Effect of Deuteration and Homologation of the Lactam Ring of Nirmatrelvir on Its Biochemical Properties and Oxidative Metabolism. Acs Bio Med Chem Au 2023 3 528 541 8UAC CATHEPSIN L IN COMPLEX WITH AC1115 2023-09-20 2024-02-07 Chao, A.,DuPrez, K.T.,Han, F.Q. CATHEPSIN L IN COMPLEX WITH AC1115 To be Published 0 0 0 0 8SIQ Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab 2023-04-16 2024-03-13 Song, G.,Yuan, M.,Liu, H.,Capozzola, T.,Lin, R.,Torres, J.,He, W.,Musharrafieh, R.,Dueker, K.,Zhou, P.,Callaghan, S.,Mishra, N.,Yong, P.,Anzanello, F.,Avillion, G.,Vo, A.,Li, X.,Makhdoomi, M.,Feng, Z.,Zhu, X.,Peng, L.,Nemazee, D.,Safonova, Y.,Briney, B.,Ward, A.,Burton, D.,Wilson, I.,Andrabi, R. Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift Biorxiv 2023 0 0 0 8TGO 38582771 Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 2023-07-12 2024-04-17 Del Moral-Sanchez, I.,Wee, E.G.,Xian, Y.,Lee, W.H.,Allen, J.D.,Torrents de la Pena, A.,Froes Rocha, R.,Ferguson, J.,Leon, A.N.,Koekkoek, S.,Schermer, E.E.,Burger, J.A.,Kumar, S.,Zwolsman, R.,Brinkkemper, M.,Aartse, A.,Eggink, D.,Han, J.,Yuan, M.,Crispin, M.,Ozorowski, G.,Ward, A.B.,Wilson, I.A.,Hanke, T.,Sliepen, K.,Sanders, R.W. Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines. Npj Vaccines 2024 9 74 74 8VZ4 L54G Mutant of E. coli Dihydrofolate Reductase Complexed with Nicotinamide Adenine Dinucleotide Phosphate (oxidized form) 2024-02-09 2024-04-17 Fried, S.D.E.,Mukherjee, S.,Mao, Y.,Boxer, S.G. Role of Electrostatics in Hydride Transfer by Dihydrofolate Reductase To Be Published 0 0 0 0 8VHA Crystal Structure of Human IDH1 R132Q in complex with NADPH and Alpha-Ketoglutarate 2023-12-31 2024-04-24 Mealka, M.,Sohl, C.D.,Huxford, T. Active site remodeling in tumor-relevant IDH1 mutants drive distinct kinetic features and possible resistance mechanisms To Be Published 0 0 0 0 8VHB Crystal Structure of Human IDH1 R132Q in complex with NADPH and Alpha-Ketoglutarate 2023-12-31 2024-04-24 Mealka, M.,Sohl, C.D.,Huxford, T. Active site remodeling in tumor-relevant IDH1 mutants drive distinct kinetic features and possible resistance mechanisms To Be Published 0 0 0 0 8VHD Crystal Structure of Human IDH1 R132Q in complex with NADPH and Isocitrate 2023-12-31 2024-04-24 Mealka, M.,Sohl, C.D.,Huxford, T. Active site remodeling in tumor-relevant IDH1 mutants drive distinct kinetic features and possible resistance mechanisms To Be Published 0 0 0 0